Search
forResearch 10 of 260
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Contemporary medical therapy for polycystic ovary syndrome
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- In Search of Predictive Models for Inhibitors of 5-alpha Reductase 2 Based on the Integration of Bioactivity and Molecular Descriptors Data.
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- Targets to treat androgen excess in polycystic ovary syndrome
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →